Hyderabad, Telangana, India – Business Wire India Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s leading integrated contract research, development, and manufacturing organizations (CRDMOs) has secured the EcoVadis Platinum Rating 2026, placing it among the top 1% of companies assessed worldwide for sustainability performance. With an overall score of 87/100 and a 99th percentile ranking, Sai Life Sciences has achieved Platinum Medal in ‘Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations’ category.
Making the announcement, Krishna Kanumuri, CEO & Managing Director, Sai Life Sciences, said, “Sustainability is becoming one of the defining measures of excellence in our industry. The ability to innovate, grow and create impact must be matched by an equal commitment to operating responsibly. Securing the EcoVadis Platinum Rating reflects the standards we have set for ourselves and the choices we have made over the years to build a resilient, future-ready organization.” EcoVadis is among the world’s most widely recognized sustainability ratings providers, assessing companies across Environment, Labour & Human Rights, Ethics, and Sustainable Procurement.
The recognition reflects sustained progress across all four EcoVadis assessment pillars. Alongside its environmental initiatives – including a 100% renewable-powered manufacturing site, significant reductions in freshwater dependency, and investments in ecosystem restoration – Sai Life Sciences has strengthened its Labour & Human Rights practices through SA8000 certification and alignment with living wage principles. The company has also enhanced governance through board-level oversight of sustainability and ethics, while reinforcing responsible procurement through supplier assessments and ISO 28000-certified supply chain security practices.
The EcoVadis Platinum Rating builds on Sai Life Sciences’ broader sustainability commitments and progress. In 2023, the company joined the Science Based Targets initiative (SBTi), committing to ambitious, science-based greenhouse gas reduction targets across its operations and value chain. In 2020, it became the first India-headquartered company to join Pharmaceutical Supply Chain Initiative (PSCI) membership. Through initiatives such as its partnership with DHL GoGreen to reduce logistics-related emissions and value-chain engagement, Sai Life Sciences continues to advance a sustainability agenda focused on measurable impact, accountability, and long-term value creation.
About Sai Life Sciences Sai Life Sciences is a full-service Contract Research, Development & Manufacturing Organization (CRDMO) working with innovator pharma and biotech companies globally to accelerate the discovery, development, and commercialization of small molecules and emerging modalities. With operations across India, the UK, and the US, Sai Life Sciences offers deep scientific expertise, world-class infrastructure, and a culture of excellence focused on quality, safety, and sustainability. For more details visit: www.sailife.com.
To View the Image, Click on the Link Below: Sai Life Sciences Achieves Ecovadis Platinum Rating, Joining the Top 1% of Companies Assessed Worldwide (Disclaimer: The above press release comes to you under an arrangement with Business Wire India and PTI takes no editorial responsibility for the same.). PTI PWR PWR PWR
(This content is sourced from a syndicated feed and is published as received. The Tribune assumes no responsibility or liability for its accuracy, completeness, or content.)